AÏDA ONCOLOGY Aps: Financial statements 2022
CVR: 42246468
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AÏDA ONCOLOGY Aps (CVR 42246468) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -179,417 and a net result of DKK -179,673. Equity in the 2022 report amounted to DKK -144,673.
- Revenue
- DKK 0
- Gross Profit
- DKK -179,417
- Profit/Loss
- DKK -179,673
- Equity
- DKK -144,673
- Total Assets
- DKK 1,008
Official annual report
Keep an eye on AÏDA ONCOLOGY Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AÏDA ONCOLOGY Aps has published its interim report for the period March 23, 2021 – December 31, 2021.
As of March 1, 2022, Ulla Hald Buhl is registered as adm. dir. of AÏDA ONCOLOGY Aps.
About AÏDA ONCOLOGY Aps
AÏDA ONCOLOGY Aps is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ulla Hald Buhl and Claus Frisenberg Pedersen. The board consists of Neil Goldsmith (chair), Claus Frisenberg Pedersen, Peter Buhl and Ulla Hald Buhl. The company's owners include Ida Kappel Buhl, BUHL KRONE HOLDING ApS and Arrow Strategy Holding 2 ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -1,913,891 and a net result of DKK -5,579,964 compared with DKK -2,613,422 the year before. Equity in the 2025 report amounted to DKK -10,698,205.